Valvular Heart Disease

Valvula​  refers to disorders affecting the heart's valves, including stenosis (narrowing) and regurgitation (leakage). These conditions can lead to heart failure and other complications if untreated. Treatment includes medication, lifestyle management, and surgery, including valve repair or replacement. The advent of transcatheter valve interventions has revolutionized the treatment of valvular heart disease, particularly in high-risk patients who may not be candidates for traditional surgery. Research continues to explore innovative valve therapies and outcomes for patients with these conditions.​

    Related Conference of Valvular Heart Disease

    August 11-12, 2025

    3rd International Conference on World Heart Care

    Toronto, Canada
    August 19-20, 2025

    29th World Cardiology Conference

    Paris, France
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Vienna, Austria
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands
    September 22-23, 2025

    14th World Heart Congress

    Dubai, UAE
    September 25-26, 2025

    13th International Conference on Hypertension and Healthcare

    Zurich, Switzerland
    October 20-21, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    March 18-19, 2026

    15th World Heart Congress

    Paris, Aland Islands

    Valvular Heart Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in